Evidence map›Paper›PMID 39268919›Full record

ArticleImmunotherapy2024

The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC.

Yiran Rong, Sujith Ramachandran, Kaustuv Bhattacharya, Yi Yang, Sally Earl, Yunhee Chang, John P Bentley

Abstract read
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yiran RongDepartment of Pharmacy Administration, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.ORCID 0000-0002-8571-3872
Sujith RamachandranAssociate Professor of Pharmacy Administration, Assistant Director for the Center for Pharmaceutical Marketing & Management, Research Associate Professor in the Research Institute of Pharmaceutical Sciences, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.
Kaustuv BhattacharyaAssistant Professor of Pharmacy Administration, Research Assistant Professor in the Research Institute of Pharmaceutical Sciences (Center for Pharmaceutical Marketing & Management), University of Mississippi, P.O. Box 1848, University, MS 38677, USA.
Yi YangProfessor of Pharmacy Administration, Chair, Department of Pharmacy Administration, Research Professor in the Research Institute of Pharmaceutical Sciences, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.
Sally EarlClinical Assistant Professor of Pharmacy Practice, Department of Pharmacy Practice, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.
Yunhee ChangProfessor, Department of Nutrition & Hospitality Management, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.
John P BentleyProfessor of Pharmacy Administration, Professor of Marketing (Joint Appointment), Director, Center for Pharmaceutical Marketing & Management, Research Professor in the Research Institute of Pharmaceutical Sciences, University of Mississippi, P.O. Box 1848, University, MS 38677, USA.

Funding

NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032I
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungImmune Checkpoint InhibitorsLung NeoplasmsAgedAged, 80 and overCohort StudiesDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleSEER ProgramUnited StatesImmune Checkpoint Inhibitorsimmune checkpoint inhibitorsimmune-related adverse eventsnon-small-cell lung cancerolder adultssurvival

Identifiers

PMID39268919
PMCPMC11492704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.